Myeloma cells can down-regulate release of osteoprotegerin (OPG) from human bone cells - A contributing factor in myeloma bone loss?

Slični predmeti

• Osteoprotegerin and the development of myeloma bone disease
  od: Croucher, P, i dr.
  Izdano: (2004)
• Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
  od: Croucher, P, i dr.
  Izdano: (2000)
• Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
  od: Croucher, P, i dr.
  Izdano: (2003)
• Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand.
  od: Shipman, C, i dr.
  Izdano: (2000)
• Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
  od: Croucher, P, i dr.
  Izdano: (2001)